Federal health officials on Tuesday introduced a new regulatory approach that narrows Covid-19 vaccine approvals primarily to older adults and individuals with heightened vulnerability to the virus.
Under the updated policy from the Food and Drug Administration (FDA), seasonal Covid-19 vaccinations will continue to be offered to seniors and people with medical conditions that increase their susceptibility to serious illness. However, healthy children and younger adults, who face significantly lower risk of severe outcomes, will no longer be the focus of broad vaccine approval.
The policy shift was detailed in a paper authored by FDA Commissioner Dr. Marty Makary and Dr. Vinay Prasad, director of the agency’s Center for Biologics Evaluation and Research. Their findings were published in the New England Journal of Medicine.
“Moving
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!